CIPO Patents = 1

EPO Patents = 3

Forward Citations = 1

Loading Chart...

14 inventors (with patents filed for the assignee):

Chun Yang (6 out of 23 patents)

Nianhe Han (6 out of 7 patents)

Deqiang An (6 out of 6 patents)

4. Di Zeng (5 out of 5 patents)

5. Baoxiang Wang (3 out of 3 patents)

6. Huali Li (3 out of 3 patents)

7. Hang Yang (3 out of 3 patents)

8. Li Jian (3 out of 3 patents)

9. Peng Fei Zhu (3 out of 33 patents)

10. Hang Chen (1 out of 4 patents)

11. Mingzhen Li (1 out of 1 patent)

12. Chengyu Hou (1 out of 1 patent)

13. Liwei Song (1 out of 1 patent)

14. Chun Yang (19 patents)

15. Nianhe Han (0 patent)

6 patents: Sort by Forward Citations

1. 12208289 - Anti-CD79b antibodies, drug conjugates, and applications thereof (2025-01-28),

2. 11666623 - Tetramaleimide linkers and use thereof (2023-06-06),

3. 11241503 - Oxadiazole linkers and use thereof (2022-02-08),

4. 10960082 - Tridentate connexon and use thereof (2021-03-30),

5. 10351593 - Derivatives of dolastatin 10 and uses thereof (2019-07-16),

6. 10314922 - Trimaleimide linkers and uses thereof (2019-06-11),

Company Overview

Newbio Therapeutics, Inc. is a biotechnology company focused on developing innovative treatments for various diseases. Our team of scientists and researchers are dedicated to bringing cutting-edge therapies to patients in need. With a strong emphasis on research and development, we strive to make a positive impact on global health.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#392 in Shanghai

#4,454 in China

Shanghai, China

Newbio Therapeutics, Inc.

Forward Citations = 1

14 inventors:

Chun Yang (6 out of 23 patents)

Nianhe Han (6 out of 7 patents)

Deqiang An (6 out of 6 patents)

4. Di Zeng (5 out of 5 patents)

5. Baoxiang Wang (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Newbio Therapeutics, Inc.. Retrieved from https://idiyas.com/company/newbio-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]